Search

Clinical Articles / BY: H.F. Kennecke, MD, MHA, FRCPC, April 2006
... of 31 months, women who switched to exemestane had a 32% reduction in the risk of recurrence, and a corresponding ... into a benefit of 6% in absolute terms. In patients with node-positive breast cancer there was also a 40% reduction in ... risk of breast cancer occurrence. Women who had low-grade node-negative disease had a very low risk (3%) of breast ...